Increasing use of ‘party drugs’ in people living with HIV on antiretrovirals
HIV and Ebola virus
Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation
The effect of KIR2D–HLA-C receptor–ligand interactions on clinical outcome in a HIV-1 CRF01_AE-infected Thai population
Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy
Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity
HIV vasculopathy
Identification of HIV-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urine
Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy
Nonvolitional sex and HIV-related sexual risk behaviours among MSM in the United States
Characterizing retention in HAART as a recurrent event process
Factors associated with abnormal spirometry among HIV-infected individuals
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa
Neurocognitive deficits increase risk of poor retention in care among older adults with newly diagnosed HIV infection
Notes on the road to perfection; use of nevirapine in combination antiretroviral therapy for children with perinatal nevirapine exposure
A cluster of rapid disease progressors upon primary HIV-1 infection shared a novel variant with mutations in the p6 gag/pol and pol/vif genes
Treatment as prevention for HIV
Raltegravir/nevirapine dual therapy at reduced doses as ‘maintenance’ treatment in virally suppressed HIV-infected patients
Psychiatric disorders after starting dolutegravir
Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood
The role of quality improvement in achieving effective large-scale prevention of mother-to-child transmission of HIV in South Africa
Improving care for patients on antiretroviral therapy through a gap analysis framework